Brazil dispute with Pfizer vaccine: pledges emergency use for AstraZeneca’s shots
View this email in your browserHappy holidays! Welcome to the 12/31/2020 edition.Brazil will soon weigh emergency-use approval for AstraZeneca’s COVID-19 vaccine after Britain gave the green light on Wednesday, as Latin America’s largest country rushes to catch up with immunization programs under way around the hard-hit region.Brazil’s health regulator Anvisa met with AstraZeneca Plc representatives said the company’s local partners, federally-funded biomedical institute Fiocruz, will file for emergency use authorization, without saying when.President Jair Bolsonaro, a prominent coronavirus skeptic who has said he will not take any COVID-19 vaccine, is under pressure to speed up Brazil’s rollout, as regional peers Mexico, Chile and Argentina have already begun immunizations. Brazil’s government has given a best-case-scenario date of Jan. 20 for AstraZeneca vaccinations to begin. Continue reading the details, in this article.Top News:Argentina’s regulator approves the AstraZeneca and Oxford University Covid-19 vaccine Argentina’s regulator on Wednesday approved the COVID-19 vaccine developed by AstraZeneca and Oxford University for emergency use, AstraZeneca said in a statement.Read on »Bolsonaro criticizes Argentina for legalizing abortion and erects as a leader of the pro-life movement  Brazil’s far-right President Jair Bolsonaro criticized a decision by Argentina’s Senate on Wednesday that gave women the right to decide on abortion. In a post on Twitter, the evangelical head of government said he “deeply regrets the lives of Argentine children,” saying they are now “exposed to being cut from their mothers’ wombs with the consent of the State.”Read on »Argentina suspends corn export sales until March; farmers’ surprised and furious  Argentina will suspend sales of corn for export until Feb. 28, the agriculture ministry said on Wednesday, announcing the surprise move as part of the government’s effort to ensure ample domestic food supplies.Read on »Brazilian medical suppliers in conflict with government over syringe and needle prices  Brazilian syringe and needle makers warned on Wednesday the country’s coronavirus vaccination program was at risk after the government set auction prices too low and failed to draw bids for enough syringes to meet its requirements.Read on »An emotional Merkel admits 2020 has been her most difficult of her 15-year leadership  Angela Merkel said in her last New Year’s address to the nation as German chancellor that 2020 was by far the most difficult of her 15-year leadership, yet the start of vaccinations against COVID-19 made 2021 a year of hope.Read on »US “will likely authorize” the AstraZeneca Oxford University vaccine next April  The COVID-19 vaccine developed by British drug maker AstraZeneca Plc and Oxford University will likely be authorized for emergency use in the United States in April, the chief adviser for the U.S. COVID-19 vaccine program said on Wednesday.Read on »British parliament approves UK/EU deal; “Brexit is not the end but a beginning” says Johnson  British lawmakers approved Prime Minister Boris Johnson’s post Brexit deal with the European Union on Wednesday, as both sides looked to begin a new chapter of relations just days before their divorce becomes a reality.Read on »Brussels and Beijing agreement to open the Chinese market to EU investors  The European Union and China on Wednesday announced the political approval of a long-sought agreement to open the Chinese market further to EU investors, marking an economic victory for both sides.Read on »Covid-19 outbreak in Wuhan had most probably ten times more cases, China public health report  The scale of the Covid-19 outbreak in Wuhan early this year may have been nearly 10 times the recorded tally, a study conducted by China’s public health authorities indicates, leaving the city where the coronavirus first took hold still well short of the immunity required to protect against a potential resurgence.Read on »Australia’s Antarctic Program MPV Everest scheduled to leave Hobart next 9 January  MPV Everest arrived in Hobart, Tasmania, on Wednesday to commence work for the Australian Antarctic Program, resupplying Australian stations and changing over personnel this summer.Read on »Want to read the full edition? Go to MercoPress’ Current Edition right now!If you liked this newsletter, please forward it to a friend and help us grow and be better. To stay in touch, you can follow us on Twitter (@MercoPressNews) or write an email to us at mercopress@mercopress.comCopyright © 2020 MercoPress, All rights reserved. Welcome Contact us: mercopress@mercopress.com |
| This email was sent to chrisbatchelor73@gmail.com why did I get this? unsubscribe from this list update subscription preferences mercopress · Montevideo · Montevideo 11000 · Uruguay |
